BACKGROUND: Few comprehensive data exist on the etiology of severe acute respiratory illness (SARI) among African children. METHODS: From March 1, 2007 to February 28, 2010, we collected blood for culture and nasopharyngeal and oropharyngeal swabs for real-time quantitative polymerase chain reaction for 10 viruses and 3 atypical bacteria among children aged <5 years with SARI, defined as World Health Organization-classified severe or very severe pneumonia or oxygen saturation <90%, who visited a clinic in rural western Kenya. We collected swabs from controls without febrile or respiratory symptoms. We calculated odds ratios for infection among cases, adjusting for age and season in logistic regression. We calculated SARI incidence, adjusting for healthcare seeking for SARI in the community. RESULTS: Two thousand nine hundred seventy-three SARI cases were identified (54% inpatient, 46% outpatient), yielding an adjusted incidence of 56 cases per 100 person-years. A pathogen was detected in 3.3% of noncontaminated blood cultures; non-typhi Salmonella (1.9%) and Streptococcus pneumoniae (0.7%) predominated. A pathogen was detected in 84% of nasopharyngeal/oropharyngeal specimens, the most common being rhino/enterovirus (50%), respiratory syncytial virus (RSV, 22%), adenovirus (16%) and influenza viruses (8%). Only RSV and influenza viruses were found more commonly among cases than controls (odds ratio 2.9, 95% confidence interval: 1.3-6.7 and odds ratio 4.8, 95% confidence interval: 1.1-21, respectively). Incidence of RSV, influenza viruses and S. pneumoniae were 7.1, 5.8 and 0.04 cases per 100 person-years, respectively. CONCLUSIONS: Among Kenyan children with SARI, RSV and influenza virus are the most likely viral causes and pneumococcus the most likely bacterial cause. Contemporaneous controls are important for interpreting upper respiratory tract specimens.
BACKGROUND: Few comprehensive data exist on the etiology of severe acute respiratory illness (SARI) among African children. METHODS: From March 1, 2007 to February 28, 2010, we collected blood for culture and nasopharyngeal and oropharyngeal swabs for real-time quantitative polymerase chain reaction for 10 viruses and 3 atypical bacteria among children aged <5 years with SARI, defined as World Health Organization-classified severe or very severe pneumonia or oxygen saturation <90%, who visited a clinic in rural western Kenya. We collected swabs from controls without febrile or respiratory symptoms. We calculated odds ratios for infection among cases, adjusting for age and season in logistic regression. We calculated SARI incidence, adjusting for healthcare seeking for SARI in the community. RESULTS: Two thousand nine hundred seventy-three SARI cases were identified (54% inpatient, 46% outpatient), yielding an adjusted incidence of 56 cases per 100 person-years. A pathogen was detected in 3.3% of noncontaminated blood cultures; non-typhi Salmonella (1.9%) and Streptococcus pneumoniae (0.7%) predominated. A pathogen was detected in 84% of nasopharyngeal/oropharyngeal specimens, the most common being rhino/enterovirus (50%), respiratory syncytial virus (RSV, 22%), adenovirus (16%) and influenza viruses (8%). Only RSV and influenza viruses were found more commonly among cases than controls (odds ratio 2.9, 95% confidence interval: 1.3-6.7 and odds ratio 4.8, 95% confidence interval: 1.1-21, respectively). Incidence of RSV, influenza viruses and S. pneumoniae were 7.1, 5.8 and 0.04 cases per 100 person-years, respectively. CONCLUSIONS: Among Kenyan children with SARI, RSV and influenza virus are the most likely viral causes and pneumococcus the most likely bacterial cause. Contemporaneous controls are important for interpreting upper respiratory tract specimens.
Authors: Leigh M Howard; Monika Johnson; John V Williams; Yuwei Zhu; Ana I Gil; Kathryn M Edwards; Marie R Griffin; Claudio F Lanata; Carlos G Grijalva Journal: Pediatr Infect Dis J Date: 2015-10 Impact factor: 2.129
Authors: Rebecca M Zash; Roger L Shapiro; Jean Leidner; Carolyn Wester; Alexander J McAdam; Richard L Hodinka; Ibou Thior; Claire Moffat; Joseph Makhema; Kenneth McIntosh; Max Essex; Shahin Lockman Journal: Paediatr Int Child Health Date: 2016-08 Impact factor: 1.990
Authors: L M Ziko; T W Hoffman; S Fwoloshi; D Chanda; Y M Nampungwe; D Patel; H Bobat; A Moonga; L Chirwa; L Hachaambwa; K J Mateyo Journal: PLoS One Date: 2022-07-15 Impact factor: 3.752
Authors: Pui-Ying Iroh Tam; Beth K Thielen; Stephen K Obaro; Ann M Brearley; Alexander M Kaizer; Haitao Chu; Edward N Janoff Journal: Vaccine Date: 2017-03-09 Impact factor: 3.641
Authors: Robert F Breiman; Leonard Cosmas; Allan Audi; William Mwiti; Henry Njuguna; Godfrey M Bigogo; Beatrice Olack; John B Ochieng; Newton Wamola; Joel M Montgomery; John Williamson; Umesh D Parashar; Deron C Burton; Jacqueline E Tate; Daniel R Feikin Journal: Pediatr Infect Dis J Date: 2014-01 Impact factor: 2.129
Authors: Philip J Budge; Marie R Griffin; Kathryn M Edwards; John V Williams; Hector Verastegui; Stella M Hartinger; Monika Johnson; Jennifer M Klemenc; Yuwei Zhu; Ana I Gil; Claudio F Lanata; Carlos G Grijalva Journal: Pediatr Infect Dis J Date: 2014-05 Impact factor: 2.129
Authors: Julia S Ampuero; Víctor Ocaña; Jorge Gómez; María E Gamero; Josefina Garcia; Eric S Halsey; V Alberto Laguna-Torres Journal: PLoS One Date: 2012-10-08 Impact factor: 3.240